December 7, 2021
Tue 6:00 PM EST
Tue 6:00 PM EST
Web
Pursuing More Effective Diagnosis and Treatment of Pompe Disease: Applying New Advances Into Practice
Catalyst Medical Education
What we are all about...
Our mission is to accelerate learning throughout the continuum of care by providing health care professionals and patients, around the world, with education that empowers change.
How we accelerate learning...
Our educational interventions speed the translation of the latest clinical data into everyday practice through strategic instructional design methods and incorporation of adult learning principles.
How we provide value...
We provide value by developing cost-effective, outcomes-driven education dedicated to improving learners’ knowledge, skills, attitudes, and behaviors—ultimately leading to better patient care.
Featured Live Events
November 16, 2022
Wed 1:00 PM EST
Wed 1:00 PM EST
Web
Wednesday, November 16th - 1PM - 2:30 PM ET
Although the recent availability of the novel enzyme replacement therapy (ERT) olipudase alfa has improved the outlook for patients with acid sphingomyelinase...
March 14, 2024
Thu 5:00 PM EDT
Thu 5:00 PM EDT
Web
Optimizing Outcomes in Late-Onset Pompe Disease: Integrating New Therapies, Whole-Person Markers for Disease Monitoring, and Shared Decision-making Into Practice
April 12, 2022
Tue 12:45 PM EDT
Tue 12:45 PM EDT
Virtual Event
Live Stream from SIMD - Exploring Next Generation ERTs for Pompe Disease
April 12, 2022
Tue 12:45 PM EDT
Tue 12:45 PM EDT
Rosen Shingle Creek Resort,...
Exploring Next Generation ERTs for Pompe Disease: Strategies for Individualizing Treatment Decisions
Tuesday, April 12, 2022 12:45-2:15 pm ET Room: Suwannee 19-21 Lunch will be served
March 16, 2024
Sat 7:30 AM CDT
Sat 7:30 AM CDT
JW Marriott Houston by The ...
The 16th Annual Johns Hopkins Multiple Sclerosis Symposium Series - Houston
Join us for an interactive, live CE-certified workshop exploring multidisciplinary strategies to enhance the diagnosis and management of MS.
May 18, 2024
Sat 7:30 AM EDT
Sat 7:30 AM EDT
Renaissance Baltimore Harbo...
The 16th Annual Johns Hopkins Multiple Sclerosis Symposium Series - Baltimore
Join us for an interactive, live CE-certified workshop exploring multidisciplinary strategies to enhance the diagnosis and management of MS.
Courses
Optimizing Outcomes in Late-Onset Pompe Disease: Integrating New Therapies, Whole-Person Markers for Disease Monitoring, and Shared Decision-making Into Practice
With the approval of 2 new entities, recent advances in enzyme replacement therapy (ERT) have created a paradigm shift in which healthcare providers (HCPs) have gone...
Exploring Next-Generation Therapies to Mitigate Disease Progression in Pompe Disease
Despite the proven benefits of enzyme replacement therapy (ERT) for patients with Pompe disease (PD), many individuals continue to experience disease progression while...
Perspectives for Pharmacy Practice: Optimizing Outcomes and Addressing Adherence Barriers to Oral Therapy in High-Risk HR+/HER2- Early Breast Cancer
The addition of the CDK4/6 inhibitor abemaciclib to adjuvant endocrine therapy (ET) improves invasive disease-free and distant recurrence-free survival in patients...
ASMD Webcast
Although the recent availability of the novel enzyme replacement therapy (ERT) olipudase alfa has improved the outlook for patients with acid sphingomyelinase...
Exploring JAK Inhibitors for Inflammatory Skin Disorders: Improving Outcomes for Atopic Dermatitis
This webinar will review the clinical manifestations and assessment of AD and provide a practical approach to AD treatment with the newer targeted agents, particularly...
Exploring JAK Inhibitors for Inflammatory Skin Disorders: Improving Outcomes for Alopecia Areata
This webinar will review the clinical manifestations and assessment of AA, along with clinical trial results with oral JAK inhibitors, which are showing promise. This...